Clinical Trials Directory

Trials / Completed

CompletedNCT01371552

Performance Evaluation of a New Daily Disposable Silicone Hydrogel Lens

Performance Evaluation of a New Daily Disposable Silicone Hydrogel Lens (TUNGSTEN)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
119 (actual)
Sponsor
CIBA VISION · Industry
Sex
All
Age
17 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study was to compare a new daily disposable, silicone hydrogel contact lens to marketed daily disposable, silicone hydrogel contact lenses.

Detailed description

Part 1 of the study involved bilateral wear of three different types of marketed contact lenses. Each type of lens was worn for three consecutive days of daily disposable wear. Participants had been previously identified as symptomatic lens wearers or asymptomatic lens wearers, based upon their responses to a screening questionnaire. Participants wore each lens type for as long as they were comfortable during the day, but lenses were removed before sleep. After completion of Part 1, participants began Part 2, which included dispensing of the investigational study lens for up to one week of bilateral wear, with a single follow-up visit at the end of that period.

Conditions

Interventions

TypeNameDescription
DEVICEdelefilcon A contact lensInvestigational, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1 and one week in Part 2.
DEVICEfilcon II 3 contact lensesCommercially marketed, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1.
DEVICEnarafilcon A contact lensesCommercially marketed, silicone hydrogel, single vision contact lens worn on a daily disposable basis for 3 days in Part 1.

Timeline

Start date
2011-05-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2011-06-13
Last updated
2012-10-31
Results posted
2012-10-31

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01371552. Inclusion in this directory is not an endorsement.